FIM
HAE icon

Freedom Investment Management’s Haemonetics HAE Stock Holding History

Freedom Investment Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-2,154
Closed -$248K – 689
2019
Q4 		$248K Buy
+2,154
New +$261K 0.02% 564
2018
Q4 		– Sell
-4,209
Closed -$474K – 819
2018
Q3 		$474K Sell
4,209
-631
-13% -$65.3K 0.03% 536
2018
Q2 		$434K Buy
+4,840
New +$409K 0.03% 616
2018
Q1 		– Sell
-6,801
Closed -$395K – 1151
2017
Q4 		$395K Sell
6,801
-1,753
-20% -$92.3K 0.02% 742
2017
Q3 		$384K Buy
8,554
+841
+11% +$34.9K 0.02% 715
2017
Q2 		$305K Buy
+7,713
New +$317K 0.02% 782

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Freedom Investment Management's HAE Position: Q1 2020 in Review

Freedom Investment Management sold out of Haemonetics (HAE) in Q1 2020, closing a stake of 2,154 shares — an estimated $248K sold.

Freedom Investment Management first reported a position in HAE in Q2 2017 and held it in 6 quarters. The position peaked at $474K in Q3 2018. 269 funds tracked by Wall St. Rank hold HAE as of Q1 2020.

  • Freedom Investment Management reported no remaining Haemonetics position as of Q1 2020 after selling out during the quarter.
  • Freedom Investment Management sold 2,154 Haemonetics shares in Q1 2020, an estimated $248K.
  • Freedom Investment Management first reported a position in Haemonetics in Q2 2017 and held it in 6 quarters.
  • Freedom Investment Management's Haemonetics position peaked at $474K in Q3 2018.
  • 269 funds tracked by Wall St. Rank held Haemonetics as of Q1 2020.

Based on Freedom Investment Management's 13F filing for Q1 2020, filed 12 May 2020.